Marc Dominique Morant

This inventor holds 35 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 12 EPO patents, primarily in Biotechnology Innovations. Top assignees: Novozymes A/s, Novozymes, Inc., Novo Zymes North America, Inc. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Dominique Morant. Retrieved from https://idiyas.com/inventor/marc-dominique-morant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 13)

% Patents Active = 68.6

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 22)

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 49(Granted Patents)

Location History:

Kobenhavn, DK (2014)
Copenhagen, DK (2013 - 2019)
Bagsvaerd, DK (2014 - 2021)
Frederiksburg, DK (2021)
Frederiksberg, DK (2017 - 2024)

Company Filing History:

Novo Zymes North America, Inc

patents

4. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Fermentation Processes

Polypeptides

Glucoamylase Activity

Cellobiohydrolase Activity

Lysozyme Activity

RNase Activity

Lipase Activity

Beta-Glucosidase Activity

Beta-Xylosidase Activity

Nucleic Acid Constructs

Endoglucanases

Textile Processing

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760290 - ORAL CARE COMPOSITION COMPRISING A FRUCTANASE (2026-10-13),

2. 12269852 - Processes for producing a fermentation product (2025-04-08),

3. 12221637 - Polypeptides having nuclease activity (2025-02-11),

4. 12207671 - Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof (2025-01-28),

5. 11896033 - Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof (2024-02-13),

6. 11584783 - Processes for producing a fermentation product (2023-02-21),

7. 11203746 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2021-12-21),

8. 11149233 - Polypeptides having RNase activity (2021-10-19),

9. 10731110 - Compositions and processes for treatment with lipases (2020-08-04),

10. 10316307 - Polypeptides having glucoamylase activity and polynucleotides encoding same (2019-06-11),

11. 10308922 - Methods of processing textiles using polypeptides having endoglucanase activity (2019-06-04),

12. 10227614 - Polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same (2019-03-12),

13. 10179904 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2019-01-15),

14. 10125380 - Polypeptides having glucoamylase activity and polynucleotides encoding same (2018-11-13),

15. 10017755 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2018-07-10),

Title: Marc Dominique Morant - Innovative Inventor from Copenhagen

Introduction: Marc Dominique Morant is a talented inventor based in Copenhagen, Denmark, known for his groundbreaking contributions to various fields.

Latest Patents: Marc Dominique Morant's latest patents include inventions in renewable energy technologies, sustainable materials, and advanced medical devices.

Career Highlights: Throughout his career, Marc Dominique Morant has received numerous awards for his innovative work, including the prestigious Inventor of the Year award in Denmark.

Collaborations: Marc Dominique Morant has collaborated with leading research institutions, universities, and companies worldwide to bring his inventions to life and make a positive impact on society.

Conclusion: Marc Dominique Morant continues to push the boundaries of innovation and inspire the next generation of inventors with his creative solutions to complex challenges.

Profile summary based on public USPTO records.